天然和合成的生物活性作为抗癌剂
Luana Vittoria Bauso1, Valeria La Fauci1, Serena Munaò1
1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres, 31, 98168 Messina, Italy.
International journal of molecular sciences
|July 13, 2024
概括
抗癌 (ACP) 为传统癌症疗法提供了一个有希望的替代方案,选择性地向癌细胞. 这些还有助于癌症诊断和治疗监测,显示出显著的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 癌症仍然是全球主要的死亡原因,传统的治疗方法,如化疗和放射治疗,具有显著的副作用.
- 由于治疗的局限性和耐药性的出现,对新型,有效的癌症治疗的需求至关重要.
- 抗癌 (ACP) 正成为癌症治疗和诊断的有前途的研究领域.
研究的目的:
- 审查天然和合成抗癌 (ACP) 的生物活性.
- 探索非洲和非洲国家在治疗常见和恶性瘤方面的潜力.
- 突出ACP在癌症诊断,向药物供应和治疗监测方面的作用.
主要方法:
- 关于抗癌的科学文献的综述.
- 对ACP的作用机制的分析,包括亡诱导,膜破坏和途径抑制.
- 检查与成像技术 (MRI,PET,CT,NIR) 结合的非洲和非洲的应用程序.
主要成果:
- 经过多种机制,ACP体现了选择性诱导癌细胞死亡的现象.
- 非洲和非洲国家/地区显示有针对性药物输送和组合治疗的潜力.
- 超过1000个临床试验表明,ACP在癌症治疗中具有有前途的应用.
- 可以通过分子成像增强癌症检测,分类和治疗反应监测.
结论:
- 抗癌代表了瘤学的重大进步,提供了有针对性和潜在的毒性较低的治疗选择.
- 在治疗,诊断和监测方面,ACP的多方面的作用强调了它们广泛的临床实用性.
- 进一步的研究和临床试验是有必要的,以充分实现ACP对各种癌症的治疗潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K